Qiuxiang Ou

26PUBLICATIONS
78CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jan 19, 2026
Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients.

Yin Yang, Yuqi Wu, Jingjing Zhao

|Oct 23, 2025
Molecular Characteristics and Treatment Implications of TP53 Gain-of-Function Mutations in Non-Small Cell Lung Cancer.

Zheng Zhao, Rui Lu, Feng Zhang

|Oct 15, 2025
Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients.

Yin Yang, Yuqi Wu, Jingjing Zhao

|Aug 31, 2025
Mutational landscape and tyrosine kinase inhibitor sensitivity in EGFR L833 and H835 mutated non-small cell lung cancer.

Long Huang, Fanxu Zeng, Peng Huang

|Nov 15, 2024
Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial.

Xin Wang, Xiaozheng Kang, Ruixiang Zhang

|Oct 17, 2024
The clinical utility of plasma circulating tumor DNA in the diagnosis and disease surveillance in non-diffuse large B-cell non-Hodgkin lymphomas.

Xiaoping Zhang, Li Yang, Minyi Zhu

Pageof 5

Frequent Collaborators

6 joint publications

Hua Bao

5 joint publications

Xiaotian Zhao

4 joint publications

Ruoying Yu

3 joint publications

Yi-Long Wu